Media Centre
Latest press releases
-
License agreement with KYM Biosciences for CMG901, a Claudin-18.2 antibody drug conjugate, completed
-
Eplontersen demonstrated sustained benefit in Phase III trial for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) through 66 weeks
-
Calquence granted first regulatory approval in China for adults with previously treated mantle cell lymphoma
-
AstraZeneca launches call for entries to the 2023 global R&D Postdoctoral Challenge
-
Tagrisso demonstrated strong overall survival benefit in the ADAURA Phase III trial for adjuvant treatment of patients with early-stage EGFR-mutated lung cancer
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
